Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2008

01.07.2008 | Preclinical Study

Risk of needle tract seeding of breast cancer: cytological results derived from core wash material

verfasst von: Takayoshi Uematsu, Masako Kasami

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Needle track seeding has been recognized as a possible, albeit rare, complication of breast core needle biopsy. The purpose of this study was to assess the risk of needle tract seeding of breast cancer from cytological results derived from core needle wash material. The study included biopsies of 207 breast cancers performed using ultrasonographically guided 18-gauge core needles. Each core needle without exposed sample notch was washed in saline solution immediately after removing the needles. Cytology derived from core wash material was performed by saline solution lavage of the fragments using a cytocentrifuge. The cytological diagnoses were divided into five categories: benign, atypical/indeterminate, suspicious/probably malignant, malignant and unsatisfactory. Atypical/indeterminate, suspicious/probably malignant and malignant categories were considered to represent positive cases of needle track seeding of breast cancer, whereas benign and unsatisfactory categories were counted as negative cases. Cytological diagnoses of the 207 lesions were as follows: 26 lesions (12%) were benign, 18 lesions (9%) were atypical/indeterminate, 37 lesions (18%) were suspicious/probably malignant, 79 lesions (38%) were malignant, and 47 lesions (23%) were unsatisfactory. The incidence of positive cases of cytology derived from core wash material was 65% (134/207). The 25% frequency of positive cases of invasive lobular carcinoma was significantly lower than the frequencies of DCIS (74%) and invasive ductal carcinoma (69%) (P = 0.001 and P < 0.01). The frequency of positive cases in the multiple passes group was 75%, which was slightly, although not significantly, higher than the 66% frequency in the single pass group (P = 0.3). In conclusion, the incidence of positive cases of cytology derived from ultrasonographically guided breast core needles’ wash material was 65%. The clinical significance is debatable; however, there may be a theoretical risk of local recurrence if the tract is not excised or radiotherapy not given.
Literatur
1.
Zurück zum Zitat Liberman L (2000) Percutaneous imaging-guided core breast biopsy: state of the art at the millennium. AJR Am J Roentgenol 174:1191–1199PubMed Liberman L (2000) Percutaneous imaging-guided core breast biopsy: state of the art at the millennium. AJR Am J Roentgenol 174:1191–1199PubMed
2.
Zurück zum Zitat Fitzal F, Sporn EP, Draxler W, Mittlbock M, Taucher S, Rudas M, Riedl O, Helbich TH, Jakesz R, Gnant M (2006) Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat 97:9–15PubMedCrossRef Fitzal F, Sporn EP, Draxler W, Mittlbock M, Taucher S, Rudas M, Riedl O, Helbich TH, Jakesz R, Gnant M (2006) Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat 97:9–15PubMedCrossRef
3.
Zurück zum Zitat Chen AM, Haffty BG, Lee CH (2002) Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. Radiology 225:707–712PubMedCrossRef Chen AM, Haffty BG, Lee CH (2002) Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. Radiology 225:707–712PubMedCrossRef
4.
Zurück zum Zitat King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM (2001) Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 7:19–24PubMedCrossRef King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM (2001) Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 7:19–24PubMedCrossRef
5.
Zurück zum Zitat Knight R, Horiuchi K, Parker SH, Ratzer ER, Frenoglio ME (2002) Risk of needle-track seeding after diagnostic image-guided core needle biopsy in breast cancer. JSLS 6:207–209PubMed Knight R, Horiuchi K, Parker SH, Ratzer ER, Frenoglio ME (2002) Risk of needle-track seeding after diagnostic image-guided core needle biopsy in breast cancer. JSLS 6:207–209PubMed
6.
Zurück zum Zitat Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173:1303–1313PubMed Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173:1303–1313PubMed
7.
Zurück zum Zitat Hoorntje LE, Schipper MEI, Kaya A, Verkooijen HM, Klinkenbijl JG, Rinkes IHMB (2004) Tumor cell displacement after 14G breast biopsy. Eur J Surg Oncol 30:520–521PubMedCrossRef Hoorntje LE, Schipper MEI, Kaya A, Verkooijen HM, Klinkenbijl JG, Rinkes IHMB (2004) Tumor cell displacement after 14G breast biopsy. Eur J Surg Oncol 30:520–521PubMedCrossRef
8.
Zurück zum Zitat Youngson BJ, Liberman L, Rosen PP (1995) Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 103:598–602PubMed Youngson BJ, Liberman L, Rosen PP (1995) Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 103:598–602PubMed
9.
Zurück zum Zitat Stolier A, Skinner J, Levine EA (2000) A prospective study of seeding of the skin after core biopsy of the breast. Am J Surg 180:104–107PubMedCrossRef Stolier A, Skinner J, Levine EA (2000) A prospective study of seeding of the skin after core biopsy of the breast. Am J Surg 180:104–107PubMedCrossRef
10.
Zurück zum Zitat Uematsu T, Kasami M, Uchida Y, Yuen S, Sanuki J, Kimura K, Tanaka K (2007) Ultrasonographically guided 18-gauge automated core needle breast biopsy with post-fire needle position verification (PNPV). Breast Cancer 14:219–228PubMedCrossRef Uematsu T, Kasami M, Uchida Y, Yuen S, Sanuki J, Kimura K, Tanaka K (2007) Ultrasonographically guided 18-gauge automated core needle breast biopsy with post-fire needle position verification (PNPV). Breast Cancer 14:219–228PubMedCrossRef
11.
Zurück zum Zitat Developed and approved at the National Cancer Institute-sponsored conference, USA (1997) The uniform approach to breast fine-needle aspiration biopsy. Cytopathology 16:295–311CrossRef Developed and approved at the National Cancer Institute-sponsored conference, USA (1997) The uniform approach to breast fine-needle aspiration biopsy. Cytopathology 16:295–311CrossRef
12.
Zurück zum Zitat Liberman L, Vuolo M, Dershaw DD, Morris EA, Abramson AF, LaTrenta LR, Polini NM, Rosen PP (1999) Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 172:677–681PubMed Liberman L, Vuolo M, Dershaw DD, Morris EA, Abramson AF, LaTrenta LR, Polini NM, Rosen PP (1999) Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 172:677–681PubMed
13.
Zurück zum Zitat Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E (2000) Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 41:435–440PubMedCrossRef Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E (2000) Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 41:435–440PubMedCrossRef
14.
Zurück zum Zitat Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, Fowble B (2001) Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature. Breast J 7:124–127PubMedCrossRef Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, Fowble B (2001) Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature. Breast J 7:124–127PubMedCrossRef
15.
Zurück zum Zitat Harter LP, Curtis JS, Ponto G, Craig PH (1992) Malignant seeding of the needle track during stereotaxic core needle breast biopsy. Radiology 185:713–714PubMed Harter LP, Curtis JS, Ponto G, Craig PH (1992) Malignant seeding of the needle track during stereotaxic core needle breast biopsy. Radiology 185:713–714PubMed
16.
Zurück zum Zitat Uriburu JL, Vuoto HD, Cogorno L, Isetta JA, Candas G, Imach GC, Bernabo OL (2006) Local recurrence of breast cancer after skin-sparing mastectomy following core needle biopsy: case reports and review of the literature. Breast J 12:194–198PubMedCrossRef Uriburu JL, Vuoto HD, Cogorno L, Isetta JA, Candas G, Imach GC, Bernabo OL (2006) Local recurrence of breast cancer after skin-sparing mastectomy following core needle biopsy: case reports and review of the literature. Breast J 12:194–198PubMedCrossRef
17.
Zurück zum Zitat Youngson BJ, Cranor M, Rosen PP (1994) Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 18:896–903PubMedCrossRef Youngson BJ, Cranor M, Rosen PP (1994) Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 18:896–903PubMedCrossRef
Metadaten
Titel
Risk of needle tract seeding of breast cancer: cytological results derived from core wash material
verfasst von
Takayoshi Uematsu
Masako Kasami
Publikationsdatum
01.07.2008
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9685-6

Weitere Artikel der Ausgabe 1/2008

Breast Cancer Research and Treatment 1/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.